Bogle Investment Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,942
Closed -$578K 64
2020
Q4
$578K Sell
2,942
-11,298
-79% -$2M 0.92% 29
2020
Q3
$2.34M Buy
+14,240
New +$2.34M 0.69% 78
2019
Q4
Sell
-65,881
Closed -$6.83M 294
2019
Q3
$6.83M Buy
65,881
+32,964
+100% +$3.54M 0.59% 69
2019
Q2
$4.22M Buy
+32,917
New +$4.57M 0.33% 102
2019
Q1
Sell
-102,271
Closed -$12.8M 346
2018
Q4
$12.8M Buy
102,271
+30,074
+42% +$5.14M 1% 14
2018
Q3
$16M Sell
72,197
-7,757
-10% -$1.57M 1.15% 15
2018
Q2
$12.8M Buy
79,954
+19,376
+32% +$2.48M 0.93% 34
2018
Q1
$5.66M Sell
60,578
-17,566
-22% -$1.31M 0.43% 92
2017
Q4
$5.46M Buy
78,144
+25,221
+48% +$1.67M 0.4% 91
2017
Q3
$3.14M Buy
+52,923
New +$2.63M 0.21% 136
2016
Q4
Sell
-15,147
Closed -$572K 372
2016
Q3
$572K Sell
15,147
-75,307
-83% -$2.7M 0.04% 293
2016
Q2
$3.01M Buy
+90,454
New +$2.92M 0.21% 143

Other funds holding MED

Bogle Investment Management's MED Position: Q1 2021 in Review

Bogle Investment Management sold out of Medifast (MED) in Q1 2021, closing a stake of 2,942 shares — an estimated $578K sold.

Bogle Investment Management first reported a position in MED in Q2 2016 and held it in 12 quarters. The position peaked at $16M in Q3 2018. 277 funds tracked by Wall St. Rank hold MED as of Q1 2021.

  • Bogle Investment Management reported no remaining Medifast position as of Q1 2021 after selling out during the quarter.
  • Bogle Investment Management sold 2,942 Medifast shares in Q1 2021, an estimated $578K.
  • Bogle Investment Management first reported a position in Medifast in Q2 2016 and held it in 12 quarters.
  • Bogle Investment Management's Medifast position peaked at $16M in Q3 2018.
  • 277 funds tracked by Wall St. Rank held Medifast as of Q1 2021.

Based on Bogle Investment Management's 13F filing for Q1 2021.